LOG IN
|
Services
|
Contact
|
Custom Research
Search
Advanced search
Main
Healthcare, Pharmaceuticals & Biotechnology
Healthcare and drugs
U.S. Nucleic Acid Isolation Markets
Publications
Business, Finance & Insurance
(35706)
Consumer Goods & Retail
(127031)
Databases & Statistics
(27)
Education & Consulting
(0)
Industry
(87698)
Healthcare, Pharmaceuticals & Biotechnology
(58540)
Biotechnology
(9100)
Pharmaceuticals
(30490)
Healthcare and drugs
(18950)
Services
(0)
Government and Public Sector
(553)
Technologies & Electronics
(91477)
Company reports
(70860)
Country reports
(2187)
(Currently 512486 Items)
Partners
Healthcare and drugs / REPORT INFORMATION
U.S. Nucleic Acid Isolation Markets
Date
Oct, 2005
Pages
0
Price / format
€3353 / Hard Copy
€2976 / Site License
€4106 / Enterprisewide
€2 951
Report Information
|
Custom-Tailored Research
|
Product Trade Lead
Abstract:
Dwindling NIH Budget Limits Market for Nucleic Acid Isolation Products
In 2004, the National Institute of Health (NIH) had just completed a five year doubling campaign involving 15 percent increases for each of the previous five years. Compared to the previous 15 percent increases, the fiscal year 2004 NIH budget slowed growth to 2.7 percent to only $26.9 billion.This dramatic decrease in funding will greatly reduce revenue for the nucleic acid isolation market.
Focus on Marketing and Product Development Efforts Towards Growing Market Segments
The shift from genomics to proteomics research should not be a limiting factor for manufacturers of nucleic acid isolation products. Research in growing areas such as molecular diagnostics and forensics should offset the shrinking genomics market. Manufacturers should take advantage of these growing market segments by addressing these areas.
The U.S. molecular diagnostics market was $984.3 million in 2003 with a growth rate of over 20 percent, according to Frost & Sullivan. In addition, this market is predicted to be close to $4 billion by 2010. The forensics market is growing at a rate of over 20 percent, as well. If manufacturers focus marketing efforts towards these high growth segments, revenues will greatly increase. In addition, manufacturers should understand the requirements in molecular diagnostics and forensics, focusing on a suited product line. Beyond molecular diagnostics
and forensics, researchers should monitor markets in other applicable segments.
Table of contents:
1. Executive Summary
1.1. Market Overview
1.1.1. Introduction
2.Total Nucleic Acid Isolation Markets
2.1. Market Overview
2.1.1. Introduction
2.1.2. Research Methodology
2.1.3. Market Engineering Analysis
2.2. Market Segmentation and Revenue Forecasts
2.2.1. Scope and Segmentation
2.2.2. Revenue Forecast
2.3. Market Challenges and Strategic Recommendations
2.3.1. Industry Challenges
2.3.2. Strategic Recommendations
2.4. Frost and Sullivan Awards
2.4.1. Growth Strategy Leadership Award
2.4.2. Market Leadership Award
2.4.3. Product Innovation Award
2.4.4.Technology Leadership Award
3. Nucleic Acid Isolation Consumables Markets
3.1. Market Overview
3.1.1. Introduction
3.1.2. Market Engineering Measurements
3.2. Market Drivers and Restraints
3.2.1. Market Drivers
3.2.2. Market Restraints
3.3.Technology and Market Trends
3.3.1.Technology Trends
3.3.2. Market Trends
3.4. Market Forecast
3.4.1. Pricing Trends
3.4.2. Revenue Forecast
3.5. Competitive Analysis
3.5.1. Competitive Structure
3.5.2. Market Share Analysis
3.5.3. Product Analysis
4. Nucleic Acid Isolation Instrumentations Markets
4.1. Market Overview
4.1.1. Introduction
4.1.2. Market Engineering Measurements
4.2. Market Drivers and Restraints
4.2.1. Market Drivers
4.2.2. Market Restraints
4.3.Technology and Market Trends
4.3.1.Technology Trends
4.3.2. Market Trends
4.4. Market Forecast
4.4.1. Pricing Trends
4.4.2. Revenue Forecast
4.5. Competitive Analysis
4.5.1. Competitive Structure
4.5.2. Market Share Analysis
4.5.3. Product Analysis
5. Decision Support Databases
5.1. Decision Support Databases
5.1.1. Number of Biotechnology Companies
5.1.2. Government R&D Investment in Biotechnology
5.1.3. Private Investment in Biotechnology
5.1.4.Total Healthcare Expenditure
5.1.5. Pharmaceutical R&D Expenditure
Order this report
Company name:
Contact person:
Phone/fax:
Email:
Comments:
Product Trade Lead
0 leads found
Add New Buy/Sell Lead
Type:
Buy
Sell
Offer:
Contacts:
Capture:
© 2007-2010 MarketReportFinder.com